Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China-Reference-Cited by-全球学者库

Multicenter study of diagnostic procedures, genetic aberration analysis, and first-line treatment of lung cancer in Jiangsu Province, China

Published:2018-01-17 Issue:3 Volume:9 Page:376-383
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Hu YangBo¹^ORCID,Hu Huan²,Miao LiYun³,Zhao Xin⁴,Gu Wei⁵,Heng Wei⁶,Meng ZiLi⁷,Feng Jian⁸,You Yi⁹,Xu XingXiang⁹,Hu Rong¹⁰,Li HaiQuan¹¹,Zhao Jie¹¹,Zhu XiaoLi¹²,Shi MeiQi¹³,Shen Li¹⁴,Zhang XiuWei¹⁵,Yin XiaoWei¹⁶,Ma Hang¹⁷,Shi MinHua¹⁸,Yu Yong¹⁸,Lv Hong¹⁹,Cai LiMing²⁰,Feng GaoHua²¹,Zhang YeQing²²,Wu Feng²³,Lv TangFeng²,Song Yong¹²

Affiliation:

1. Department of Respiratory Medicine, Jinling Hospital; Medical School of Southeast University; Nanjing China

2. Department of Respiratory Medicine, Jinling Hospital; Nanjing University School of Medicine; Nanjing China

3. Department of Respiratory Medicine; Nanjing University Affiliated Drum Tower Hospital; Nanjing China

4. Department of Respiratory Medicine; Nanjing Medical University Affiliated First Hospital; Nanjing China

5. Department of Respiratory Medicine; First People's Hospital of Nanjing City; Nanjing China

6. Department of Respiratory Medicine; Soochow University Affiliated First Hospital; Suzhou China

7. Department of Respiratory Medicine, First People's Hospital of Huai'an City; Nanjing Medical University; Huai'an China

8. Department of Respiratory Medicine; Nantong University Affiliated Hospital; Nantong China

9. Department of Respiratory Medicine; Subei People's Hospital; Yangzhou China

10. Department of Respiratory Medicine; First People's Hospital of Lianyungang City; Lianyungang China

11. Department of Respiratory Medicine; General Hospital of Xuzhou Mining Group; Xuzhou China

12. Department of Respiratory Medicine, Zhongda Hospital, School of Medicine; Southeast University; Nanjing China

13. Department of Respiratory Medicine, Jiangsu Cancer Hospital; Nanjing Medical University; Nanjing China

14. Department of Respiratory Medicine; Nanjing Medical University Affiliated Second Hospital; Nanjing China

15. Department of Respiratory Medicine; Nanjing Medical University Affiliated Jiangning Hospital; Nanjing China

16. Department of Respiratory Medicine; Second People's Hospital of Changzhou City; Changzhou China

17. Department of Respiratory Medicine; First People's Hospital of Nantong City; Nantong China

18. Department of Respiratory Medicine; Soochow University Affiliated Second Hospital; Suzhou China

19. Department of Respiratory Medicine; Taicang Hospital of Traditional Chinese Medicine; Suzhou China

20. Department of Respiratory Medicine; Fourth People's Hospital of Wuxi City; Wuxi China

21. Department of Respiratory Medicine; Zhangjiagang Hospital of Traditional Chinese Medicine; Suzhou China

22. Department of Respiratory Medicine; Nanjing Hospital of integrated Chinese and Western Medicine; Nanjing China

23. Department of Respiratory Medicine; First People's Hospital of Yangzhou City; Yangzhou China

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12588/fullpdf

Reference19 articles.

1. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

2. National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China;Xue;Lung Cancer,2012

3. Lung cancer treatment disparities in China: A question in need of an answer;Yang;Oncologist,2014

4. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506);Zhou;BMC Cancer,2017

5. Chinese consensus on early diagnosis of primary lung cancer (2014 version);Hu;Cancer,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma;International Journal of General Medicine;2022-02